|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang W, Zheng C, Fang C, Li P, Xie J, Lin
J, Zhan Y, Li W, Chen Y, Sun X, et al: Time trends of
clinicopathologic features and surgical treatment for gastric
cancer: Results from 2 high-volume institutions in southern China.
Surgery. 158:1590–1597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li ZX and Kaminishi M: A comparison of
gastric cancer between Japan and China. Gastric Cancer. 12:52–53.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bolke E, Peiper M and Budach W:
Capecitabine and oxaliplatin for advanced esophagogastric cancer. N
Engl J Med. 358:19652008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang YJ, Liu JZ, Lv P, Dang Y, Gao JY and
Wang Y: Long non-coding RNA CCAT2 promotes gastric cancer
proliferation and invasion by regulating the E-cadherin and LATS2.
Am J Cancer Res. 6:2651–2660. 2016.PubMed/NCBI
|
|
6
|
Nakadai T, Fukuda A, Shimada M, Nishimura
K and Hisatake K: The RNA binding complexes NF45-NF90 and
NF45-NF110 associate dynamically with the c-fos gene and function
as transcriptional coactivators. J Biol Chem. 290:26832–26845.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Agnoletto C, Brunelli L, Melloni E,
Pastorelli R, Casciano F, Rimondi E, Rigolin GM, Cuneo A, Secchiero
P and Zauli G: The anti-leukemic activity of sodium dichloroacetate
in p53mutated/null cells is mediated by a p53-independent ILF3/p21
pathway. Oncotarget. 6:2385–2396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang W, Huang H, Ding L, Zhu P, Saiyin H,
Ji G, Zuo J, Han D, Pan Y, Ding D, et al: Regulation of cell cycle
of hepatocellular carcinoma by NF90 through modulation of cyclin E1
mRNA stability. Oncogene. 34:4460–4470. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu Q, Lu YY, Noh H, Hong S, Dong Z, Ding
HF, Su SB and Huang S: Interleukin enhancer-binding factor 3
promotes breast tumor progression by regulating sustained
urokinase-type plasminogen activator expression. Oncogene.
32:3933–3943. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiu M, Zhou Y, Jin Y, Wei XL, Wang DS, Ren
C, Bai L, Yang DJ and Xu RH: Prognostic effect of high pretreatment
neutrophil to lymphocyte ratio on survival of patients with gastric
adenocarcinoma in China. Int J Biol Markers. 30:e96–e103. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang
XK, Luo RZ, Yun JP, Xie D, Li YF and Cai MY: The prognostic
significance of lymphovascular invasion in patients with resectable
gastric cancer: A large retrospective study from Southern China.
BMC Cancer. 15:3702015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Q, Bi JJ, Tian YT, Feng Q, Zheng ZX
and Wang Z: Outcome after simultaneous resection of gastric primary
tumour and synchronous liver metastases: survival analysis of a
single-center experience in China. Asian Pac J Cancer Prev.
16:1665–1669. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Sun Z, Han Y, Yao R, Yue L, Xu Y
and Zhang J: Rnf2 knockdown reduces cell viability and promotes
cell cycle arrest in gastric cancer cells. Oncol Lett.
13:3817–3822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei S, Li Q, Li Z, Wang L, Zhang L and Xu
Z: Correction: miR-424-5p promotes proliferation of gastric cancer
by targeting Smad3 through TGF-β signaling pathway. Oncotarget.
8:340182017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jia S, Qu T, Wang X, Feng M, Yang Y, Feng
X, Ma R, Li W, Hu Y, Feng Y, et al: KIAA1199 promotes migration and
invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression
and serves as a poor prognosis marker in gastric cancer. PLoS One.
12:e01750582017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Ye J, Chen Z, Wen J, Li F, Su P, Lin
Y, Hu B, Wu D, Ning L, et al: Annonaceous acetogenins mediated
up-regulation of Notch2 exerts growth inhibition in human gastric
cancer cells in vitro. Oncotarget. 8:21140–21152.
2017.PubMed/NCBI
|
|
18
|
Castella S, Bernard R, Corno M, Fradin A
and Larcher JC: Ilf3 and NF90 functions in RNA biology. Wiley
Interdiscip Rev RNA. 6:243–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li T, Li X, Zhu W, Wang H, Mei L, Wu S,
Lin X and Han X: NF90 is a novel influenza A virus NS1-interacting
protein that antagonizes the inhibitory role of NS1 on PKR
phosphorylation. FEBS Lett. 590:2797–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jayachandran U, Grey H and Cook AG:
Nuclear factor 90 uses an ADAR2-like binding mode to recognize
specific bases in dsRNA. Nucleic Acids Res. 44:1924–1936. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wan C, Gong C, Ji L, Liu X, Wang Y, Wang
L, Shao M, Yang L, Fan S, Xiao Y, et al: NF45 overexpression is
associated with poor prognosis and enhanced cell proliferation of
pancreatic ductal adenocarcinoma. Mol Cell Biochem. 410:25–35.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Masuda K, Kuwano Y, Nishida K, Rokutan K
and Imoto I: NF90 in posttranscriptional gene regulation and
microRNA biogenesis. Int J Mol Sci. 14:17111–17121. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ovestad IT, Dalen I, Hansen E, Loge JL,
Dybdahl BM, Dirdal MB, Moltu P and Berland JM: Clinical value of
fully automated p16/Ki-67 dual staining in the triage of
HPV-positive women in the Norwegian Cervical Cancer Screening
Program. Cancer. 125:283–291. 2017.
|
|
24
|
Wang FL, Yang Y, Liu ZY, Qin Y and Jin T:
Correlation between methylation of the p16 promoter and cervical
cancer incidence. Eur Rev Med Pharmacol Sci. 21:2351–2356.
2017.PubMed/NCBI
|
|
25
|
Wang LL, Guo HH, Zhan Y, Feng CL, Huang S,
Han YX, Zheng WS and Jiang JD: Specific up-regulation of p21 by a
small active RNA sequence suppresses human colorectal cancer
growth. Oncotarget. 8:25055–25065. 2017.PubMed/NCBI
|
|
26
|
Li LH, Wu GY, Lu YZ, Chen XH, Liu BY,
Zheng MH and Cai JC: p21-activated protein kinase 1 induces the
invasion of gastric cancer cells through c-Jun NH2-terminal
kinase-mediated activation of matrix metalloproteinase-2. Oncol
Rep. 38:193–200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng R, Liu YJ, Cui JW, Yang M, Liu XL,
Li P, Wang Z, Zhu LZ, Lu SY, Zou L, et al: Aspirin regulation of
c-myc and cyclinD1 proteins to overcome tamoxifen resistance in
estrogen receptor-positive breast cancer cells. Oncotarget.
8:30252–30302. 2017.PubMed/NCBI
|
|
28
|
Kim Y, Kim H, Park D, Lee H, Lee YS, Choe
J, Kim YM, Jeon D and Jeoung D: The pentapeptide
Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by
inhibition of CAGE binding to GSK3β and decreasing the expression
of cyclinD1. Oncotarget. 8:13632–13651. 2017.PubMed/NCBI
|
